Oncology & Cancer
Ovarian cancer outcomes may improve with 'dose-dense' chemotherapy
Dose-dense chemotherapy has shown promise in smaller clinical trials, and now is being investigated in a multi-center, phase III study in which nearly 700 women will participate. Earlier phase II trials pointed to anti-cancer ...
Jun 30, 2011
0
0
